Cynara scolymus extracts for the treatment of dyslipidaemia
AssigneeIndena S.p.A.
InventorEzio Bombardelli
Life of this patent
Estimating the term…
Abstract
The present invention relates to the preparation of Cynara scolymus leaf extracts, which are useful for the prevention and treatment of dyslipidaemia, in particular to increase HDL cholesterol in patients at cardiovascular risk. Said extracts are useful to normalise the lipid and carbohydrate balances and significantly increase the value of HDL cholesterol by favourably changing the LDL/HDL ratio, especially in post-infarction patients with drug-induced dyslipidaemia.
Claims9
Extract of the leaves of Cynara species varieties having a caffeoylquinic acid content of 30 to 45%, a flavonoid content of 8 to 16% and a cynaropicrin content of 10 to 18%.
Dependencies are inferred from the claim text.